Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients
Journal of Lipid Research · 2026-05 · 67 (5) · 101024
DOI: 10.1016/j.jlr.2026.101024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2026-05. Verfasst von Youngwoo Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Gachon University Gil Medical Center, Incheon, South Korea; Gachon University, College of Medicine, Incheon, South Korea. Hauptthemen laut MEDLINE: Fenofibrate, Triglycerides, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipoproteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gil Medical Center, Gachon University, Gachon University, College of Medicine, Drexel University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Gachon University Gil Medical Center, Incheon, South Korea; Gachon University, College of Medicine, Incheon, South Korea.
- Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul, South Korea.
- Department of Medical Informatics and Biostatistics, Graduate School, Yonsei University, Seoul, South Korea.
- Department of Precision Medicine, Wonju College of Medicine, Yonsei University, Wonju, South Korea.
- K-Heart Clinic & Lab, Incheon, South Korea.
- Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,…
Förderung
- Gil Medical Center, Gachon University
- Gachon University
- College of Medicine, Drexel University
Zitieren
APA
Jang, Y., Kim, B. J., Jeong, Y. W., Kang, D. R., Koh, K. K., Nordestgaard, B. G., & Han, S. H. (2026). Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. Journal of Lipid Research, 67(5), 101024. https://doi.org/10.1016/j.jlr.2026.101024
Vancouver
Jang Y, Kim BJ, Jeong YW, Kang DR, Koh KK, Nordestgaard BG, et al. Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. Journal of Lipid Research. 2026;67(5):101024. doi:10.1016/j.jlr.2026.101024
BibTeX
@article{Jang2026,
author = {Jang, Youngwoo and Kim, Byung Jin and Jeong, Yong Whi and Kang, Dae Ryong and Koh, Kwang Kon and Nordestgaard, Børge G and Han, Seung Hwan},
title = {Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients},
journal = {Journal of Lipid Research},
year = {2026},
volume = {67},
number = {5},
pages = {101024},
doi = {10.1016/j.jlr.2026.101024}
}
EUVIMED